This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Graceway Pharmaceuticals, LLC, Medicis Pharmaceutical Corporation. Active years: 2010-2014.
Company Filing History:
1 out of 7 
1 out of 71 
Years Active: 2010-2014
Title: Angela M Ginkel: Innovator in Basal Cell Carcinoma Treatment
Introduction
Angela M Ginkel is a notable inventor based in Saint Paul, MN (US). She has made significant contributions to the field of medicine, particularly in the treatment of basal cell carcinoma. With a total of 2 patents to her name, Ginkel's work is paving the way for innovative therapeutic methods.
Latest Patents
Ginkel's latest patents focus on a method for treating basal cell carcinoma. The invention provides a treatment cycle that includes administering an effective amount of an IRM compound for at least two consecutive days, followed by at least one day without administration. This innovative approach aims to enhance the effectiveness of the treatment for patients suffering from this type of skin cancer.
Career Highlights
Throughout her career, Angela M Ginkel has worked with prominent companies in the pharmaceutical industry. Notably, she has been associated with Medicis Pharmaceutical Corporation and Graceway Pharmaceuticals, LLC. Her experience in these organizations has contributed to her expertise in developing effective treatments.
Collaborations
Ginkel has collaborated with several professionals in her field, including Terrance L Fox and Mary L Owens. These collaborations have likely enriched her research and development efforts, leading to her successful innovations.
Conclusion
Angela M Ginkel stands out as a dedicated inventor whose work in treating basal cell carcinoma is making a significant impact. Her innovative methods and collaborations reflect her commitment to advancing medical treatments.